To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of a Single Dose Regimen of Ferroquine and Artefenomel in Adults and Children With Uncomplicated Plasmodium Falciparum Malaria
Stopped All treatment arms met the futility criteria for efficacy during the pre-planned interim analysis, therefore the study was stopped.
Conditions
- Plasmodium Falciparum Infection
Interventions
- DRUG: Ferroquine SSR97193
- DRUG: Artefenomel
- OTHER: Placebo
Sponsor
Sanofi
Collaborators